Rockefeller Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $73.2M | Buy |
844,234
+124,285
| +17% | +$11.9M | 0.13% | 155 |
|
|
2025
Q4 | $69.2M | Buy |
719,949
+118,110
| +20% | +$11.5M | 0.12% | 155 |
|
|
2025
Q3 | $57.3M | Buy |
601,839
+6,670
| +1% | +$613K | 0.11% | 175 |
|
|
2025
Q2 | $51.9M | Buy |
595,169
+82,350
| +16% | +$6.98M | 0.11% | 178 |
|
|
2025
Q1 | $46.1M | Buy |
512,819
+84,850
| +20% | +$7.59M | 0.11% | 175 |
|
|
2024
Q4 | $34.2M | Sell |
427,969
-76,876
| -15% | -$6.65M | 0.09% | 219 |
|
|
2024
Q3 | $45.5M | Sell |
504,845
-6,262
| -1% | -$527K | 0.12% | 172 |
|
|
2024
Q2 | $40.2M | Buy |
511,107
+38,924
| +8% | +$3.19M | 0.11% | 176 |
|
|
2024
Q1 | $41.2M | Sell |
472,183
-82,476
| -15% | -$7.04M | 0.12% | 181 |
|
|
2023
Q4 | $45.7M | Buy |
554,659
+5,243
| +1% | +$400K | 0.15% | 148 |
|
|
2023
Q3 | $43M | Sell |
549,416
-59
| -0% | -$4.94K | 0.17% | 142 |
|
|
2023
Q2 | $47.8M | Buy |
549,475
+17,768
| +3% | +$1.53M | 0.19% | 138 |
|
|
2023
Q1 | $42.9M | Sell |
531,707
-147,162
| -22% | -$12M | 0.18% | 130 |
|
|
2022
Q4 | $52.8M | Sell |
678,869
-1,160,940
| -63% | -$94.1M | 0.27% | 95 |
|
|
2022
Q3 | $149M | Sell |
1,839,809
-31,384
| -2% | -$2.82M | 0.77% | 13 |
|
|
2022
Q2 | $168M | Buy |
1,871,193
+366,333
| +24% | +$37.1M | 0.89% | 14 |
|
|
2022
Q1 | $167M | Sell |
1,504,860
-6,774
| -0.4% | -$716K | 0.81% | 14 |
|
|
2021
Q4 | $156M | Buy |
1,511,634
+432,412
| +40% | +$50.1M | 0.73% | 20 |
|
|
2021
Q3 | $135M | Buy |
1,079,222
+16,598
| +2% | +$2.15M | 0.71% | 23 |
|
|
2021
Q2 | $132M | Buy |
1,062,624
+63,000
| +6% | +$7.91M | 0.74% | 23 |
|
|
2021
Q1 | $118M | Buy |
999,624
+39,329
| +4% | +$4.61M | 0.8% | 22 |
|
|
2020
Q4 | $112M | Buy |
960,295
+5,475
| +0.6% | +$603K | 0.85% | 20 |
|
|
2020
Q3 | $99.2M | Sell |
954,820
-7,208
| -0.7% | -$724K | 0.93% | 17 |
|
|
2020
Q2 | $88.2M | Buy |
962,028
+48,424
| +5% | +$4.64M | 0.92% | 18 |
|
|
2020
Q1 | $82.4M | Sell |
913,604
-344,383
| -27% | -$36.6M | 1.08% | 19 |
|
|
2019
Q4 | $143M | Sell |
1,257,987
-96,741
| -7% | -$10.6M | 1.78% | 9 |
|
|
2019
Q3 | $147M | Sell |
1,354,728
-8,390
| -0.6% | -$875K | 2% | 10 |
|
|
2019
Q2 | $133M | Buy |
1,363,118
+5,380
| +0.4% | +$491K | 1.85% | 12 |
|
|
2019
Q1 | $124M | Buy |
1,357,738
+7,939
| +0.6% | +$711K | 1.76% | 15 |
|
|
2018
Q4 | $123M | Buy |
1,349,799
+21,955
| +2% | +$2.05M | 2.15% | 11 |
|
|
2018
Q3 | $131M | Sell |
1,327,844
-246,125
| -16% | -$22.8M | 1.98% | 14 |
|
|
2018
Q2 | $135M | Buy |
1,573,969
+205,395
| +15% | +$17.2M | 2.19% | 11 |
|
|
2018
Q1 | $110M | Buy |
+1,368,574
| New | +$113M | 1.81% | 14 |
|
Other funds holding MDT
VCM
VPM
Rockefeller Capital Management's MDT Position: Q1 2026 in Review
Rockefeller Capital Management increased its Medtronic (MDT) stake by 17% in Q1 2026, buying an estimated $11.9M and bringing the position to 844,234 shares worth $73.2M. The position accounts for 0.13% of the portfolio, ranked #155.
Rockefeller Capital Management first reported a position in MDT in Q1 2018 and has held it in 33 quarters since. The position peaked at $168M in Q2 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Rockefeller Capital Management held 844,234 shares of Medtronic worth $73.2M as of Q1 2026.
- Rockefeller Capital Management bought 124,285 Medtronic shares in Q1 2026, an estimated $11.9M.
- Medtronic made up 0.13% of Rockefeller Capital Management's portfolio in Q1 2026, its #155 holding.
- Rockefeller Capital Management first reported a position in Medtronic in Q1 2018 and has held it in 33 quarters since.
- Rockefeller Capital Management's Medtronic position peaked at $168M in Q2 2022.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.